Variant report
Variant | esv2763562 |
---|---|
Chromosome Location | chr1:74397778-74410352 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538088811 | chr1:74397859-74397860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542612521 | chr1:74397880-74397881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143282987 | chr1:74397905-74397906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562391713 | chr1:74397939-74397940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575034994 | chr1:74398010-74398011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545359246 | chr1:74398049-74398050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529564351 | chr1:74398067-74398068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542469964 | chr1:74398111-74398112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560883444 | chr1:74398121-74398122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12082647 | chr1:74398127-74398128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs540213764 | chr1:74398167-74398168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565010508 | chr1:74398179-74398180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532227385 | chr1:74398183-74398184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550545476 | chr1:74398236-74398237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562653358 | chr1:74398245-74398246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182293253 | chr1:74398277-74398278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530987443 | chr1:74398289-74398290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548428657 | chr1:74398298-74398299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375670798 | chr1:74398341-74398342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533957836 | chr1:74398347-74398348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552137033 | chr1:74398396-74398397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537108809 | chr1:74408674-74408675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs72685866 | chr1:74408747-74408748 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs534111701 | chr1:74408782-74408783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193256677 | chr1:74408783-74408784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34167477 | chr1:74408955-74408956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577459110 | chr1:74408972-74408973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545070107 | chr1:74408978-74408979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556951098 | chr1:74408991-74408992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576752393 | chr1:74408993-74408994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575421298 | chr1:74408995-74408996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs1671057 | chr1:74409027-74409028 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538998234 | chr1:74409033-74409034 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560798387 | chr1:74409104-74409105 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533900519 | chr1:74409128-74409129 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540044207 | chr1:74409154-74409155 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565228230 | chr1:74409155-74409156 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532256980 | chr1:74409197-74409198 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs202153215 | chr1:74409200-74409201 | Active TSS Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552199693 | chr1:74409204-74409205 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550569156 | chr1:74409222-74409223 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572378897 | chr1:74409265-74409266 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540294460 | chr1:74409266-74409267 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542819266 | chr1:74409268-74409269 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530157950 | chr1:74409290-74409291 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548305625 | chr1:74409295-74409296 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs59514829 | chr1:74409406-74409407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150224304 | chr1:74409444-74409445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372877903 | chr1:74409455-74409456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534448077 | chr1:74409462-74409463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:74396400-74398200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr1:74398200-74398400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr1:74408600-74410000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr1:74408600-74410000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr1:74408800-74409000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr1:74408800-74409000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr1:74408800-74409600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr1:74409000-74409200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
9 | chr1:74409000-74409400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr1:74409000-74409400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr1:74409000-74409400 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
12 | chr1:74409000-74409400 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
13 | chr1:74409000-74409400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr1:74409000-74409600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr1:74409200-74409400 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr1:74409200-74409600 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr1:74409200-74409600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr1:74409400-74409800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr1:74409400-74409800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr1:74409400-74410000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr1:74410000-74415000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |